BSML (BSML) Appoints Dr. Julian Feneley as new CEO
More News related to BSML
- BSML (BSML) Appoints Dr. Julian Feneley as new CEO
- 06/19 StreetInsider.com Unusual 11 Mid-Day Movers
- The Dow Falls 1 Point, Nasdaq Drops 14
- BriteSmile (BSML) Higher on Chatter of New Bid
- A Look at Yesterday's Momentum Movers: BSML, CHNR, ZLC, POZN & HANS
BSML, Inc., formerly known as BriteSmile, Inc., (Nasdaq: BSML) announced that its CEO and President, John Reed, will leave the Company on November 15, 2006. Dr. Julian Feneley, a current director of the Company who previously served as its President, will re-join the Company on November 15, 2006 as its CEO and President.
Dr. Feneley began working with BriteSmile as a consultant in January 2002, focusing on strategic and development initiatives, and was appointed President of the Company in February 2004. Until 2000, Dr. Feneley headed the European healthcare investment banking franchise of J P Morgan. Prior to joining J P Morgan in 1990, Dr. Feneley qualified and worked as a medical doctor at the renowned Guy's Hospital in London, England.
Related Categories
Management ChangesStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
